4 May 2018

Children denied cancer drug on cost grounds

Health and Social Care Editor

Children with a rare form of cancer will not get a new drug on the NHS. The treatment offers hope of extending life, or even curing the disease.

The National Institute for Health and Care Excellence, or NICE, issued interim guidance today saying the drug was too expensive. Now families say they are faced with going abroad or raising hundreds of thousands of pounds. Clinicians and charities are calling on the government to intervene.